[1]简立国△,刘士超,丁同斌,等.硝普钠处理急性心肌梗死经皮冠状动脉介入治疗中无复流现象的临床疗效和安全性[J].郑州大学学报(医学版),2014,(06):848.
 JIAN Liguo,LIU Shichao,DING Tongbin,et al.Clinical efficacy and safety of nitroprusside disposed noreflow phenomenon for patients with acute myocardial infarction during percutaneous coronary intervention[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(06):848.
点击复制

硝普钠处理急性心肌梗死经皮冠状动脉介入治疗中无复流现象的临床疗效和安全性
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2014年06期
页码:
848
栏目:
应用研究
出版日期:
2014-11-20

文章信息/Info

Title:
Clinical efficacy and safety of nitroprusside disposed noreflow phenomenon for patients with acute myocardial infarction during percutaneous coronary intervention
作者:
简立国△刘士超丁同斌赵江涛程栋
郑州大学第二附属医院心内科 郑州 450014
Author(s):
JIAN Liguo LIU ShichaoDING TongbinZHAO JiangtaoCHENG Dong
Department of Cardiovascular,the Second Affiliated Hospital,Zhengzhou University,Zhengzhou 450014
关键词:
硝普钠急性心肌梗死经皮冠状动脉介入治疗无复流
Keywords:
nitroprussideacute myocardial infarctionpercutaneous coronary interventionnoreflow
分类号:
R541.1
摘要:
目的:评价硝普钠处理急性心肌梗死(AMI)经皮冠状动脉介入治疗(PCI)中无复流现象的临床疗效和安全性。方法:选择PCI术中出现无复流现象的72例AMI患者为研究对象,分为硝普钠组36例和硝酸甘油组36例。针对PCI术中出现的无复流现象,两组经微导管向冠状动脉病变远端分别迅速注入硝普钠或硝酸甘油,10 min后行冠状动脉造影进行靶血管TIMI血流分级;比较两组术中和术后24 h血压、术后30 d内主要不良心血管事件(MACE)发生情况及超声心动图测定的左室射血分数(LVEF)和左室舒张末内径(LVEDD)。结果:两组TIMI靶血管血流分级差异无统计学意义(P=0.262);术中和术后24 h血压均未出现较大幅度变化(P>0.05);术后30 d内两组MACE发生率差异无统计学意义(P>0.05);术后30 d硝普钠组LVEF、LVEDD均优于硝酸甘油组(t=2.330、4.908,P<0.05)。结论:经微导管向冠状动脉病变远端注入硝普钠可有效处理在AMI患者PCI术中出现的无复流现象,安全易行。
Abstract:
Aim: To evaluate the clinical efficacy and safety of nitroprusside disposed noreflow phenomenon for patients with acute myocardial infarction(AMI) during percutaneous coronary intervention(PCI). Methods: A total of 72 patients with AMI who had noreflow phenomenon during PCI treatment were divided into nitroprusside group(n=36) and nitroglycerin group(n=36). Nitroprusside or nitroprusside was rapidly injected into the distal coronary artery lesions through micro catheter, and 10 min later, TIMI flow grade was assessed by coronary angiography. Blood pressure of intraoperative and 24 h after operation, major adverse cardiovascular events(MACE) incidence and the cardiac function(LVEF and LVEDD) in the first thirty days after PCI were compared between the two groups. Results: There was no significant difference in TIMI flow grade(P=0.262) and MACE incidence(P>0.05) between the two groups; intraoperative and postoperative blood pressure were not significantly changed(P>0.05). LVEF and LVEDD were higher in nitroprusside group(t=2.330,4.908,P<0.05).Conclusion: Nitroprusside could effectively dispose noreflow phenomenon in patients with AMI during PCI, and is safe and easy.

参考文献/References:

[1]Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials[J].Lancet,2003,361(9351):13 [2]陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:284 [3]胡大一,马长生.心脏病学实践2012:规范化治疗[M].北京:人民卫生出版社,2012:127 [4]霍勇,张澍.卫生部心血管疾病介入诊疗技术培训教材:冠心病分册[M].北京:人民卫生出版社,2009:265 [5]马长生.冠心病介入治疗:技术与策略[M].北京:人民卫生出版社,2004:266 [6]李占全,金元哲.冠状动脉造影与临床[M].沈阳:辽宁科学技术出版社,2001:66 [7]Romano M,Buffoli F,Tomasi L,et al.The noreflow phenomenon in acute myocardial infarction after primary angioplasty:incidence,predictive factors,and longterm outcomes[J].J Cardiovasc Med (Hagerstown),2008,9(1):59 [8]Brosh D,Assali AR,Mager A,et al.Effect of noreflow during primary percutaneous coronary intervention for acute myocardial infarction on sixmonth mortality[J].Am J Cardiol,2007,99(4):442 [9]吴婕,顾烨.硝普钠在无复流现象中的应用[J].中国循环研究杂志,2006,1(4):255 [10]Shinozaki N,Ichinose H,Yahikozawa K,et al.Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction[J].Int Heart J,2007,48(4):423 [11]Youssef AA,Wu CJ,Hang CL,et al.Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on noreflow phenomenon following primary percutaneous coronary intervention[J].Circ J,2006,70(12):1538 [12]Pasceri V,Pristipino C,Pellicia F,et al.Effects of nitric oxide donor nitropfusside on noreflow phenomenon during coronary intervention for acute myocardial infarction[J].Am J Cardiol,2005,95(11):1358 [13]Zhao YJ,Fu XH,Ma XX,et al.Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the noreflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction[J].Exp Ther Med,2013,6(2):479

相似文献/References:

[1]梁鹍)△,牛颖),魏经汉).内皮祖细胞自体移植联合阿托伐他汀治疗大鼠急性心肌梗死效果观察[J].郑州大学学报(医学版),2009,(06):1197.
 LIANG Kun),NIU Ying),WEI Jinghan).Effects of autologous endothelial progenitor cells transplantation plus atorvastatin treatment on acute myocardial infarction of rats[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(06):1197.
[2]危林松.早期药物联合心理干预治疗急性心肌梗死后并发抑郁症42例[J].郑州大学学报(医学版),2010,(05):872.
[3]李彬,朱锐,何家富,等.血栓抽吸对急性ST段抬高型心肌梗死患者近期预后的影响[J].郑州大学学报(医学版),2012,(01):123.
[4]刘旭帮,张丽华#,李小威,等.比索洛尔对急性心肌梗死大鼠梗死周边区心肌组织中KCNE1和KCNE2表达的影响[J].郑州大学学报(医学版),2012,(02):228.
 LIU Xubang,ZHANG Lihua,LI Xiaowei,et al.Effect of bisoprolol on KCNE1 and KCNE2 expressions in myocardial infarction border zone of rats after acute myocardial infarction[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2012,(06):228.
[5]樊清波)△,简立国).不同剂量阿托伐他汀对急性心肌梗死急诊行PCI患者血清骨桥蛋白的影响[J].郑州大学学报(医学版),2012,(06):869.
[6]娄唯鸣.血栓抽吸前替罗非班冠状动脉内注射在急性ST段抬高型心肌梗死患者中的应用[J].郑州大学学报(医学版),2012,(06):870.
[7]孙涛,万大国#,宋恒良,等.瑞舒伐他汀对大鼠急性心肌梗死后梗死组织miR126的表达及血管再生的影响[J].郑州大学学报(医学版),2013,(05):640.
 SUN Tao,WAN Daguo,SONG Hengliang,et al.Effects of rosuvastatin on angiogenesis and expression of miR126 after acute myocardial infarction in rats[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2013,(06):640.
[8]段娜娜),王绍欣)#,王丽平),等.经皮冠状动脉封堵法制备中华小型猪急性心肌梗死模型及血清HFABP动态变化的观察[J].郑州大学学报(医学版),2015,(01):78.
 DUAN Nana),WANG Shaoxin),WANG Liping),et al.Establishment of AMI Chinese miniswine model with percutaneous coronary occlusion and observation on dynamic change of serum HFABP level[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(06):78.

备注/Memo

备注/Memo:
△男,1971年9月生,博士,副主任医师,研究方向:心血管病的介入诊治,Email:jlg0919@163.com
更新日期/Last Update: 2014-11-26